
Cryo-Cell International, Inc.: shareholders and insiders
Price
$4.85
November 13, 2026Market cap $39M
What Ploutos Investor adds for Cryo-Cell International
Part of Ploutos Investor, €9.99 a month
- The full history: 16 fiscal years, from FY2010
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors from Nov 16, 2025 to Oct 28, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
–
nobody
From Nov 16, 2025 to Nov 16, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
No trades under these filters.
From the Form 4s insiders file with the SEC within two business days of each trade.
Insiders and their shares
Every buy and sale by CCEL's officers and directors from 2007 up to November 15, 2025, 19 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 14 more, back to 2007
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Camac Partners, LLCwith 3 more personsShare of class6.80%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Camac Partners, LLCwith 3 more persons | 6.80% | 551.1K | Jul 7, 20262 filings since Mar 25, 2026 | 13D/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Camac Partners, LLC6.8%From the filing of Jul 7, 2026
The Reporting Persons purchased the securities of the Issuer reported herein based on the Reporting Persons' belief that such securities, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of securities of the Issuer at prices that would make the purchase or sale of such securities desirable, the Reporting Persons may endeavor to (i) increase or decrease their respective positions in the Issuer through, among other things, the purchase or sale of securities of the Issuer on the open market or in private transactions or…
From the filing of Jul 7, 2026
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- CDMJ Nyberg Family Trust0.00%Dec 27, 202413G
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
No well-known manager
None of the managers we track held Cryo-Cell International shares in their latest 13F.
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 0.09% of its shares outstanding were held short, +10.2% since the report before.
- Shares held short
- 7,070
- 0.09%
- Since the report before6,416 on Sep 30, 2026
- +10.2%
- under 1
- 18.7K
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 18.5K
- Nov 15, 2023: Shares held short 20.2K
- Nov 30, 2023: Shares held short 17.0K
- Dec 15, 2023: Shares held short 12.0K
- Dec 29, 2023: Shares held short 13.6K
- Jan 12, 2024: Shares held short 12.1K
- Jan 31, 2024: Shares held short 12.3K
- Feb 15, 2024: Shares held short 12.2K
- Feb 29, 2024: Shares held short 11.0K
- Mar 15, 2024: Shares held short 26.5K
- Mar 28, 2024: Shares held short 21.9K
- Apr 15, 2024: Shares held short 16.9K
- Apr 30, 2024: Shares held short 16.2K
- May 15, 2024: Shares held short 17.4K
- May 31, 2024: Shares held short 11.6K
- Jun 14, 2024: Shares held short 10.9K
- Jun 28, 2024: Shares held short 16.3K
- Jul 15, 2024: Shares held short 15.6K
- Jul 31, 2024: Shares held short 10.8K
- Aug 15, 2024: Shares held short 8,690
- Aug 30, 2024: Shares held short 5,190
- Sep 13, 2024: Shares held short 4,336
- Sep 30, 2024: Shares held short 12.3K
- Oct 15, 2024: Shares held short 8,742
- Oct 31, 2024: Shares held short 13.6K
- Nov 15, 2024: Shares held short 14.7K
- Nov 29, 2024: Shares held short 20.2K
- Dec 13, 2024: Shares held short 19.0K
- Dec 31, 2024: Shares held short 18.3K
- Jan 15, 2025: Shares held short 15.7K
- Jan 31, 2025: Shares held short 16.2K
- Feb 14, 2025: Shares held short 15.7K
- Feb 28, 2025: Shares held short 14.8K
- Mar 14, 2025: Shares held short 4,878
- Mar 31, 2025: Shares held short 4,948
- Apr 15, 2025: Shares held short 6,296
- Apr 30, 2025: Shares held short 3,732
- May 15, 2025: Shares held short 5,703
- May 30, 2025: Shares held short 9,370
- Jun 13, 2025: Shares held short 7,440
- Jun 30, 2025: Shares held short 8,030
- Jul 15, 2025: Shares held short 8,211
- Jul 31, 2025: Shares held short 11.0K
- Aug 15, 2025: Shares held short 11.2K
- Aug 29, 2025: Shares held short 14.6K
- Sep 15, 2025: Shares held short 6,093
- Sep 30, 2025: Shares held short 10.9K
- Oct 15, 2025: Shares held short 8,986
- Oct 31, 2025: Shares held short 10.3K
- Nov 14, 2025: Shares held short 5,598
- Nov 28, 2025: Shares held short 8,014
- Dec 15, 2025: Shares held short 7,332
- Dec 31, 2025: Shares held short 6,968
- Jan 15, 2026: Shares held short 6,982
- Jan 30, 2026: Shares held short 7,376
- Feb 13, 2026: Shares held short 9,430
- Feb 27, 2026: Shares held short 8,789
- Mar 13, 2026: Shares held short 5,712
- Mar 31, 2026: Shares held short 10.9K
- Apr 15, 2026: Shares held short 7,936
- Apr 30, 2026: Shares held short 7,016
- May 15, 2026: Shares held short 9,834
- May 29, 2026: Shares held short 14.7K
- Jun 15, 2026: Shares held short 9,904
- Jun 30, 2026: Shares held short 6,372
- Jul 15, 2026: Shares held short 9,249
- Jul 31, 2026: Shares held short 8,977
- Aug 14, 2026: Shares held short 12.7K
- Aug 31, 2026: Shares held short 5,662
- Sep 15, 2026: Shares held short 9,061
- Sep 30, 2026: Shares held short 6,416
- Oct 15, 2026: Shares held short 7,070
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading27.7% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 27.7% of the shares in the reported trades were short sales, against 42.9% in the 14 before.
- Last 14 sessionsOct 27, 2026 – Nov 13, 2026
- 27.7%
- The 14 beforeOct 7, 2026 – Oct 26, 2026
- 42.9%
- Change
- -15.2 pts
- Short sales a dayon average, of 3,336 shares
- 925
- More than atof 3,649 US-listed companies, same days
- 4%
- Median of alleight in ten from 34.6% to 63.4%
- 50.1%
- Short sales
- Oct 7, 2026: Short sales 11.1%
- Oct 8, 2026: Short sales 80%
- Oct 9, 2026: Short sales 42.3%
- Oct 12, 2026: Short sales 35.9%
- Oct 13, 2026: Short sales 31%
- Oct 14, 2026: Short sales 19.9%
- Oct 15, 2026: Short sales 43.3%
- Oct 16, 2026: Short sales 56.3%
- Oct 19, 2026: Short sales 62%
- Oct 20, 2026: Short sales 24.4%
- Oct 21, 2026: Short sales 55.4%
- Oct 22, 2026: Short sales 5.4%
- Oct 23, 2026: Short sales 40.3%
- Oct 26, 2026: Short sales 50.7%
- Oct 27, 2026: Short sales 6.7%
- Oct 28, 2026: Short sales 49.4%
- Oct 29, 2026: Short sales 44.9%
- Oct 30, 2026: Short sales 4.5%
- Nov 2, 2026: Short sales 13.9%
- Nov 3, 2026: Short sales 16.3%
- Nov 4, 2026: Short sales 37%
- Nov 5, 2026: Short sales 7.2%
- Nov 6, 2026: Short sales 4.9%
- Nov 9, 2026: Short sales 47.8%
- Nov 10, 2026: Short sales 6.5%
- Nov 11, 2026: Short sales 28.9%
- Nov 12, 2026: Short sales 27.8%
- Nov 13, 2026: Short sales 39.4%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
A lower bound: it counts only the 2 officers and directors with a market trade since Nov 17, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
1 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 20
- Q4 2025: Managers 17
- Q1 2026: Managers 11
- Q2 2026: Managers 12
Institutional investors by quarter
The fund managers holding CCEL, quarter by quarter, from Q4 2016 to Q2 2025, 35 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 12 managers held 555.1K shares, worth $1.8M. During the quarter 2 opened a position, 1 closed one, 4 added and 2 trimmed.
The largest holders, Q2 2026
- SFI AdvisorsIn the quarter
- Vanguard Capital ManagementIn the quarter+2.1%
- MassMutual Private Wealth & Trust, FSBIn the quarter
- Geode Capital ManagementIn the quarter+6.1%
- Vanguard Fiduciary TrustIn the quarter
- FMRIn the quarter
- Susquehanna International GroupIn the quarter+40%
- BlackRockIn the quarter-52%
- Osaic HoldingsIn the quarter
- Morgan StanleyIn the quarter+0.7%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| SFI Advisors | 165.3K | $527.3K | |
| Vanguard Capital Management | 165.0K | +2.1% | $526.3K |
| MassMutual Private Wealth & Trust, FSB | 111.0K | $354.2K | |
| Geode Capital Management | 46.3K | +6.1% | $147.7K |
| Vanguard Fiduciary Trust | 23.3K | $74.5K | |
| FMR | 20.0K | $63.8K | |
| Susquehanna International Group | 14.1K | +40% | $44.9K |
| BlackRock | 6,696 | -52% | $21.4K |
| Osaic Holdings | 2,500 | $8.0K | |
| Morgan Stanley | 605 | +0.7% | $1.9K |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Cryo-Cell International's filings show?
Who buys and sells is one part of Cryo-Cell International's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have CCEL's insiders bought or sold?
From May 29, 2026 to Oct 28, 2026 Cryo-Cell International's insiders reported no purchase or sale of shares on the market.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.